CD44 and Leigh syndrome: Hierarchical clustering showed these 19 populations to assemble in three distinct groups, where clusters in group 1 were dominated by cells from LS patients and defined by a significant reduction in adhesion molecule CD44 compared to background cells (i.e., all CD4+ T cells).